The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition

키워드

참고문헌 (68)

1. "Maternal, newborn, child and adolescent health"[URL]
2. ESPGHAN Committee on Nutrition, "Breast-feeding : a commentary by the ESPGHAN Committee on Nutrition", J Pediatr Gastroenterol Nutr, 49, pp.112~125 (2009)
3. Lönnerdal B, "An opinion on"staging"of infant formula-a developmental perspective on infant feeding", J Pediatr Gastroenterol Nutr, 62, pp.9~21 (2016)
4. Bode L, "Human milk oligosaccharides : every baby needs a sugar mama", Glycobiology, 22, pp.1147~1162 (2012)
5. Xu G, "Absolute quantitation of human milk oligosaccharides reveals phenotypic variations during lactation", J Nutr, 147, pp.117~124 (2017)
6. Chaturvedi P, "Fucosylated human milk oligosaccharides vary between individuals and over the course of lactation", Glycobiology, 11, pp.365~372 (2001)
7. Thurl S, "Variation of human milk oligosaccharides in relation to milk groups and lactational periods", Br J Nutr, 104, pp.1261~1271 (2010)
8. Kunz C, "Food Oligosaccharides: Production, Analysis and Bioactivity", pp.5~20 (2014), John Wiley & Sons, Ltd
9. Zivkovic AM, "Human milk glycobiome and its impact on the infant gastrointestinal microbiota", Proc Natl Acad Sci U S A, 108(Suppl 1), pp.4653~4658 (2011)
10. Smilowitz JT, "Breast milk oligosaccharides : structure-function relationships in the neonate", Annu Rev Nutr, 34, pp.143~169 (2014)
11. Sprenger N, "Longitudinal change of selected human milk oligosaccharides and association to infants' growth, an observatory, single center, longitudinal cohort study", PLoS One, 12, pp.e0171814~ (2017)
12. Grönlund MM, "Fecal microflora in healthy infants born by different methods of delivery : permanent changes in intestinal flora after cesarean delivery", J Pediatr Gastroenterol Nutr, 28, pp.19~25 (1999)
13. Renz-Polster H, "Caesarean section delivery and the risk of allergic disorders in childhood", Clin Exp Allergy, 35, pp.1466~1472 (2005)
14. Goldani HA, "Cesarean delivery is associated with an increased risk of obesity in adulthood in a Brazilian birth cohort study", Am J Clin Nutr, 93, pp.1344~1347 (2011)
15. Cardwell CR, "Caesarean section is associated with an increased risk of childhood-onset type 1 diabetes mellitus : a meta-analysis of observational studies", Diabetologia, 51, pp.726~735 (2008)
16. Harmsen HJ, "Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods", J Pediatr Gastroenterol Nutr, 30, pp.61~67 (2000)
17. Yasmin F, "Caesarean section, formula feeding, and infant antibiotic exposure : separate and combined impacts on gut microbial changes in later infancy", Front Pediatr, 5, pp.200~ (2017)
18. Mikkelsen KH, "Use of antibiotics in childhood and risk of type 1 diabetes : a population-based case-control study", Diabet Med, 34, pp.272~277 (2017)
19. Azad MB, "Infant antibiotic exposure and the development of childhood overweight and central adiposity", Int J Obes, 38, pp.1290~1298 (2014)
20. Wu P, "Relative importance and additive effects of maternal and infant risk factors on childhood asthma", PLoS One, 11, pp.e0151705~ (2016)
21. Ilić K, "Social-economic factors and irrational antibiotic use as reasons for antibiotic resistance of bacteria causing common childhood infections in primary healthcare", Eur J Pediatr, 171, pp.767~777 (2012)
22. Hviid A, "Antibiotic use and inflammatory bowel diseases in childhood", Gut, 60, pp.49~54 (2011)
23. Kronman MP, "Antibiotic exposure and IBD development among children : a population-based cohort study", Pediatrics, 130, pp.e794~803 (2012)
24. Francino MP, "Antibiotics and human gut microbiome : dysbioses and accumulation of resistances", Front Microbiol, 6, pp.1543~ (2016)
25. Mulder B, "Prenatal exposure to acid-suppressive drugs and the risk of allergic diseases in the offspring : a cohort study", Clin Exp Allergy, 44, pp.261~269 (2014)
26. Lewis ZT, "Maternal fucosyltransferase 2 status affects the gut bifidobacterial communities of breastfed infants", Microbiome, 3, pp.13~ (2015)
27. Morrow AL, "Human milk oligosaccharides are associated with protection against diarrhea in breast-fed infants", J Pediatr, 145, pp.297~303 (2004)
28. Bode L, "The functional biology of human milk oligosaccharides", Early Hum Dev, 91, pp.619~622 (2015)
29. Salminen S, "Regulatory aspect of human milk oligosaccharides", Nestle Nutr Inst Workshop Ser, 88, pp.161~170 (2017)
30. Hoeflinger JL, "In vitro impact of human milk oligosaccharides on Enterobacteriaceae growth", J Agric Food Chem, 63, pp.3295~3302 (2015)
31. Bode L, "Human milk oligosaccharide concentration and risk of postnatal transmission of HIV through breastfeeding", Am J Clin Nutr, 96, pp.831~839 (2012)
32. LoCascio RG, "Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation", J Agric Food Chem, 55, pp.8914~8919 (2007)
33. Marcobal A, "Consumption of human milk oligosaccharides by gut-related microbes", J Agric Food Chem, 58, pp.5334~5340 (2010)
34. Asakuma S, "Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria", J Biol Chem, 286, pp.34583~34592 (2011)
35. Bunesova V, "Fucosyllactose and L-fucose utilization of infant Bifidobacterium longum and Bifidobacterium kashiwanohense", BMC Microbiol, 16, pp.248~ (2016)
36. Garrido D, "A novel gene cluster allows preferential utilization of fucosylated milk oligosaccharides in Bifidobacterium longum subsp. longum SC596", Sci Rep, 6, pp.35045~ (2016)
37. Gibson GR, "Regulatory effects of bifidobacteria on the growth of other colonic bacteria", J Appl Bacteriol, 77, pp.412~420 (1994)
38. Thongaram T, "Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli", J Dairy Sci, 100, pp.7825~7833 (2017)
39. Puccio G, "Effects of infant formula with human milk oligosaccharides on growth and morbidity : a randomized multicenter trial", J Pediatr Gastroenterol Nutr, 64, pp.624~631 (2017)
40. Angeloni S, "Glycoprofiling with micro-arrays of glycoconjugates and lectins", Glycobiology, 15, pp.31~41 (2005)
41. Yu ZT, "The human milk oligosaccharide 2′-fucosyllactose quenches Campylobacter jejuni-induced inflammation in human epithelial cells HEp-2 and HT-29 and in mouse intestinal mucosa", J Nutr, 146, pp.1980~1990 (2016)
42. Ruiz-Palacios GM, "Campylobacter jejuni binds intestinal H(O)antigen(Fucα1, 2Galβ1, 4GlcNAc), and fucosyloligosaccharides of human milk inhibit its binding and infection", J Biol Chem, 278, pp.14112~14120 (2003)
43. Morrow AL, "Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea", J Nutr, 135, pp.1304~1307 (2005)
44. Idänpään-Heikkilä I, "Oligosaccharides interfere with the establishment and progression of experimental pneumococcal pneumonia", J Infect Dis, 176, pp.704~712 (1997)
45. Lin AE, "Human milk oligosaccharides inhibit growth of group B Streptococcus", J Biol Chem, 292, pp.11243~11249 (2017)
46. Moukarzel S, "Human milk oligosaccharides and the preterm infant : a journey in sickness and in health", Clin Perinatol, 44, pp.193~207 (2017)
47. Autran CA, "Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants", Gut, 67, pp.1064~1070 (2018)
48. Good M, "The human milk oligosaccharide 2′-fucosyllactose attenuates the severity of experimental necrotising enterocolitis by enhancing mesenteric perfusion in the neonatal intestine", Br J Nutr, 116, pp.1175~1187 (2016)
49. Kuntz S, "Oligosaccharides from human milk induce growth arrest via G2", M by influencing growth-related cell cycle genes in intestinal epithelial cells, 2009, pp.101, 1306~1315
50. Holscher HD, "Human milk oligosaccharides influence maturation of human intestinal Caco-2Bbe and HT-29 cell lines", J Nutr, 144, pp.586~591 (2014)
51. Kulinich A, "Human milk oligosaccharides : The role in the fine-tuning of innate immune responses", Carbohydr Res, 432, pp.62~70 (2016)
52. Donovan SM, "Human milk oligosaccharides influence neonatal mucosal and systemic immunity", Ann Nutr Metab, 69(Suppl 2), pp.42~51 (2016)
53. Goehring KC, "Similar to those who are breastfed, infants fed a formula containing 2′-fucosyllactose have lower inflammatory cytokines in a randomized controlled trial", J Nutr, 146, pp.2559~2566 (2016)
54. Comstock SS, "Dietary human milk oligosaccharides but not prebiotic oligosaccharides increase circulating natural killer cell and mesenteric lymph node memory T cell populations in noninfected and rotavirus-infected neonatal piglets", J Nutr, 147, pp.1041~1047 (2017)
55. Castillo-Courtade L, "Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model", Allergy, 70, pp.1091~1102 (2015)
56. He Y, "The human milk oligosaccharide 2′-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation", Gut, 65, pp.33~46 (2016)
57. Bienenstock J, "Fucosylated but not sialylated milk oligosaccharides diminish colon motor contractions", PLoS One, 8, pp.e76236~ (2013)
58. Jacobi SK, "Dietary isomers of sialyllactose increase ganglioside sialic acid concentrations in the corpus callosum and cerebellum and modulate the colonic microbiota of formula-fed piglets", J Nutr, 146, pp.200~208 (2016)
59. Matthies H, "Fucose and fucosyllactose enhance in-vitro hippocampal long-term potentiation", Brain Res, 725, pp.276~280 (1996)
60. Vázquez E, "Effects of a human milk oligosaccharide, 2′-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents", J Nutr Biochem, 26, pp.455~465 (2015)
61. Tarr AJ, "The prebiotics 3′Sialyllactose and 6′Sialyllactose diminish stressor-induced anxiety-like behavior and colonic microbiota alterations : evidence for effects on the gut-brain axis", Brain Behav Immun, 50, pp.166~177 (2015)
62. Hahn WH, "The human milk oligosaccharides are not affected by pasteurization and freeze-drying", J Matern Fetal Neonatal Med, 32, pp.985~991 (2019)
63. Daniels B, "The effect of simulated flash heating pasteurisation and Holder pasteurisation on human milk oligosaccharides", Paediatr Int Child Health, 37, pp.204~209 (2017)
64. Marriage BJ, "Infants fed a lower calorie formula with 2′FL show growth and 2′FL uptake like breast-fed infants", J Pediatr Gastroenterol Nutr, 61, pp.649~658 (2015)
65. Kajzer J, "Gastrointestinal tolerance of formula supplemented with oligosaccharides", FASEB J, 30(Suppl), pp.671~674 (2016)
66. Clinical safety of a new starter infant formula containing 2 human milk oligosaccharides (HMOs), complete report, "Janas B", Nestlé, ~ (2015)
67. Prieto PA, "In vitro and clinical experiences with a human milk oligosaccharide, lacto-N-neoTetraose, and fructooligosaccharides", Food Foods Ingredients J Jpn, 210, pp.1018~1030 (2005)
68. EFSA Panel on Dietetic Products, Nutrition, and Allergies (NDA), "Safety of 2′-O-fucosyllactose as a novel food ingredient pursuant to regulation (EC) No 258", 97, 2015, pp.13, 4184~

관련 논문AI추천